Financhill
Back

Eagle Pharmaceuticals Stock Predictions

Eagle Pharmaceuticals Stock Forecast

  • Is Eagle Pharmaceuticals Stock Undervalued?
    The current Eagle Pharmaceuticals [EGRX] share price is $0.95. The Score for EGRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • EGRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Eagle Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Eagle Pharmaceuticals Stock Rating

Data Unavailable

Eagle Pharmaceuticals Stock Price History

Is EGRX stock going to rise?

  • The current trend is relatively stagnant and EGRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
eagleus.com

52-Week Data

52-Week High:
9.00
52-Week Low:
0.00

Prediction Charts

Market Cap:
12.34M
Price in USD:
0.95
Volume:
12K
Beta:
0.86

Technical Analysis

SMA50:
1.63
SMA100:
3.27
SMA200:
4.08
52-Wk Change:
-89.44%

Stock Predictions

  • Is Eagle Pharmaceuticals stock public?
    Yes, Eagle Pharmaceuticals is a publicly traded company.
  • What is the Eagle Pharmaceuticals stock quote today?
    The Eagle Pharmaceuticals stock price is 0.95 USD today.
  • How to buy Eagle Pharmaceuticals stock online?
    You can buy Eagle Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 0.60 0.80 0.85 0.60
Nov-6 0.55 0.80 0.95 0.55
Nov-7 0.85 0.85 0.90 0.60
Nov-8 0.65 0.85 0.90 0.65
Nov-11 0.88 0.85 0.88 0.49
Nov-12 0.80 0.90 0.95 0.75
Nov-13 0.90 0.75 1.00 0.75
Nov-14 1.00 0.70 1.00 0.70
Nov-15 0.82 0.65 0.82 0.65
Nov-18 0.69 0.90 0.90 0.65
Nov-19 0.65 0.65 0.99 0.65
Nov-20 0.65 0.65 0.72 0.65
Nov-21 0.74 0.90 0.95 0.70
Nov-22 0.95 0.95 0.95 0.65

Eagle Pharmaceuticals Earnings

Data Unavailable

Eagle Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.

* Eagle Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.